Soares Karen

Insider profile

Performance

Overall performance
3.4

Performance over holding periods
3.4
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 92% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Soares Karen's trades of Clover Health Investments, Corp.'s stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-15 2026-09-15 S Sale
55,243 +7.3%
214.93
US$473,136
55,243 +7.3% 214.93 US$473,136
2026-09-15 2026-09-15 PrS Proposed sale
21,150
256.06
US$3,587,091
21,150 256.06 US$3,587,091
2026-07-20 2026-07-20 PlS Planned sale
35,790 +45.6%
119.33
US$830,855
35,790 +45.6% 119.33 US$830,855
2026-07-20 2026-07-20 PrS Proposed sale
51,700
4.62
US$238,854
51,700 4.62 US$238,854
2026-07-16 2026-07-15 S Sale
10,519 -0.7%
4.67
US$49,124
10,519 -0.7% 4.67 US$49,124
2026-07-15 2026-07-15 PrS Proposed sale
10,192
4.68
US$47,699
10,192 4.68 US$47,699
2026-06-16 2026-06-15 S Sale
4,681 -0.3%
4.61
US$21,579
4,681 -0.3% 4.61 US$21,579
2026-06-15 2026-06-15 PrS Proposed sale
5,342
4.81
US$25,695
5,342 4.81 US$25,695
2025-03-07 2025-03-06 S Sale
52,500 -3.9%
3.80
US$199,500
52,500 -3.9% 3.80 US$199,500
2025-03-06 2025-03-06 PrS Proposed sale
75,000
3.68
US$276,269
75,000 3.68 US$276,269
2025-03-06 2025-03-05 PrS Proposed sale
52,500
3.80
US$199,500
52,500 3.80 US$199,500